Enfamil NeuroPro vs. Similac 360 Total Care

Enfamil NeuroPro and Similac 360 Total Care are the flagship products of the two largest formula brands in the United States. They represent the top tier of each company's product line and carry premium pricing to match.

Both formulas share the same nutritional foundation — they meet all FDA requirements under 21 CFR 107, use cow's milk protein, and provide the standard macro and micronutrient profile that every infant formula must deliver. Where they diverge is in their proprietary bioactive additions: Enfamil adds MFGM, and Similac adds a blend of HMOs.

These are real components of human breast milk, and both have legitimate research behind them. But "legitimate research" and "proof that your baby will be smarter or healthier" are not the same thing. Understanding the difference between what the evidence shows and what the marketing implies is the key to making an informed decision.

For a general comparison of the parent brands, see our Enfamil vs. Similac guide.

MFGM stands for milk fat globule membrane. In breast milk, fat is delivered in globules surrounded by a membrane rich in phospholipids, sphingomyelin, cholesterol, and glycoproteins. This membrane is not just packaging — research suggests it plays roles in brain development, gut maturation, and immune function.

The key study Enfamil cites is the Timby et al. (2014) randomized controlled trial from Sweden. In this study, 160 infants were randomized to receive either standard formula or formula supplemented with a bovine MFGM concentrate. At 12 months, the MFGM group scored higher on the Bayley Scales of Infant Development (cognitive subscale) compared to the standard formula group, and their scores were closer to a breastfed reference group.

This is a genuinely interesting finding. But context matters. This was a single study with a relatively small sample size. The cognitive difference, while statistically significant, was modest. There is no published long-term follow-up showing whether the difference persists at age 2, 3, or 5. And the study was partially funded by industry.

The Lasekan et al. (2015) study demonstrated that MFGM-supplemented formula is safe and well-tolerated with normal growth — important for establishing safety, but not evidence of cognitive benefit.

Bottom line: MFGM is a real, biologically relevant component of breast milk. Adding it to formula is scientifically reasonable. But the evidence that it produces measurable, lasting cognitive improvements in healthy, full-term, formula-fed babies is preliminary, not established.

HMOs (human milk oligosaccharides) are complex sugars that are the third most abundant solid component of breast milk, after lactose and fat. Breast milk contains over 200 distinct HMOs. They are not digested by the baby — instead, they feed beneficial gut bacteria (acting as prebiotics), directly block pathogens from attaching to gut cells, and modulate the immune system.

Similac 360 Total Care includes five HMOs, with 2'-fucosyllactose (2'-FL) as the primary one. The Marriage et al. (2015) study showed that formula with 2'-FL HMO was well-tolerated, supported normal growth, and that the HMO was absorbed and excreted in patterns similar to breastfed infants. Parents also reported lower rates of respiratory infections and eczema.

The Puccio et al. (2017) study tested formula with 2'-FL and LNnT (another HMO) and found lower rates of parent-reported respiratory infections and antibiotic use in the HMO group compared to standard formula.

These are encouraging results. HMOs clearly play important roles in breast milk, and adding them to formula is scientifically reasonable. But the studies rely heavily on parent-reported outcomes (which are subjective), the sample sizes are moderate, and the research is industry-funded. Breast milk delivers over 200 HMOs in complex interactions — adding 5 synthesized versions is a meaningful start but a fraction of the breast milk HMO profile.

Bottom line: HMOs are biologically important, and including them in formula is a reasonable scientific step. But the evidence that adding 5 synthesized HMOs produces the same benefits as the 200+ HMOs in breast milk is incomplete.

Here is what gets lost between the clinical research and the formula aisle:

The base nutrition is the same. Strip away MFGM and HMOs, and you have two formulas with the same protein, similar fat profiles, lactose as the carbohydrate, and the same FDA-required nutrients. The premium ingredients are additions on top of an identical nutritional foundation.

No study has shown long-term outcome differences. As of 2026, there is no published research demonstrating that children who were fed MFGM-supplemented or HMO-supplemented formula have better cognitive function, stronger immune systems, or better health outcomes at age 2, 5, or 10 compared to children fed standard formula. The studies are short-term, and infant development is influenced by hundreds of factors beyond formula composition.

The premium price is paying for the bioactive ingredients. The $5-10 per can price difference between premium and standard formulas from the same brand amounts to roughly $60-120 per year. Whether that investment is "worth it" is a personal values question, not a medical one. The base nutrition your baby needs is fully covered by standard formulas.

Both companies are marketing to parental anxiety. "Brain development" and "immune support" are loaded phrases designed to make parents feel that anything less than the premium option is shortchanging their baby. This is not true. Millions of healthy children were raised on standard formula before MFGM and HMO supplementation existed. These ingredients are potential optimizations, not requirements.

Store brands are catching up. Some store-brand formulas now include 2'-FL HMO. None currently include MFGM. But the base nutritional profile of store brands meets the same FDA requirements at 30-50% lower cost.

The choice between NeuroPro and 360 Total Care does not require a medical consultation for healthy babies — pick whichever your baby tolerates and your budget supports. However, talk to your pediatrician in these situations:

Enfamil NeuroPro and Similac 360 Total Care are both well-formulated, safe, nutritionally complete formulas. Their signature ingredients — MFGM and HMOs — are biologically relevant compounds found in breast milk, with some clinical research supporting their addition to formula.

However, the evidence does not demonstrate that one is superior to the other, and it does not prove that either produces meaningfully better long-term outcomes than standard (non-premium) formulas. The base nutrition is the same. The premium price reflects the bioactive additions, which are scientifically interesting but not proven necessities.

Choose based on what your baby tolerates, what is available, and what your budget allows. If the premium price feels comfortable, go for it — there is no downside. If it is a stretch, standard formula (from either brand or a store brand) provides everything your baby needs nutritionally. No guilt required.

If you are switching between formulas or comparing how your baby does on different products, tracking feeds and growth for a couple of weeks gives you real data to reference. Tinylog makes it simple to log feeds and see patterns, so you can make decisions based on observation rather than marketing.

For comparisons of the gentle and sensitive lines, see our Enfamil Gentlease vs. Similac Sensitive guide. For how newer brands compare, see our Bobbie vs. Enfamil vs. Similac guide.

• Enfamil vs. Similac — A complete comparison

• Best Baby Formulas 2026 — An evidence-based guide

• U.S. Food and Drug Administration. "21 CFR Part 107 — Infant Formula." Code of Federal Regulations.
• Timby N, et al. "Neurodevelopment, nutrition, and growth until 12 months of age in infants fed a low-energy, low-protein formula supplemented with bovine MFGM." American Journal of Clinical Nutrition, 2014.
• Lasekan JB, et al. "Growth of newborn, term infants fed sn-2 palmitate-predominant fat formula." Clinical Pediatrics, 2015.
• Marriage BJ, et al. "Infants fed a lower calorie formula with 2'-FL show growth and 2'-FL uptake similar to breastfed infants." Journal of Pediatric Gastroenterology and Nutrition, 2015.
• Puccio G, et al. "Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial." Journal of Pediatric Gastroenterology and Nutrition, 2017.
• Bode L. "Human milk oligosaccharides: every baby needs a sugar mama." Glycobiology, 2012.
• American Academy of Pediatrics. "Choosing an Infant Formula." HealthyChildren.org, 2024.

This guide is for informational purposes only and is not a substitute for professional medical advice. Formula choices should be discussed with your pediatrician if your baby has specific medical conditions, allergies, or feeding concerns.